Vladimir Poroikov

researcher

Vladimir Poroikov is …
instance of (P31):
humanQ5

External links are
P2456DBLP author ID69/5693
P8079elibrary.ru person ID80992
P496ORCID iD0000-0001-7937-2621
P3829Publons author ID2575908
P1053ResearcherIDO-2769-2013
P1153Scopus author ID7004294720

P1477birth nameВладимир Васильевич Поройков
P69educated atMoscow State UniversityQ13164
P108employerInstitute of Biomedical ChemistryQ19908058
P735given nameVladimirQ2253934
VladimirQ2253934
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q92282181(Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like Compounds
Q5432358520(th) EuroQSAR: Understanding Chemical-Biological Interactions.
Q989434363-Amino-5-(indol-3-yl)methylene-4-oxo-2-thioxothiazolidine Derivatives as Antimicrobial Agents: Synthesis, Computational and Biological Evaluation
Q47355938A QSAR and molecular modelling study towards new lead finding: polypharmacological approach to Mycobacterium tuberculosis.
Q56973932A new approach to QSAR modelling of acute toxicity†
Q45156706A new statistical approach to predicting aromatic hydroxylation sites. Comparison with model-based approaches
Q47366719ADVERPred-Web Service for Prediction of Adverse Effects of Drugs.
Q48139169Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice
Q90988745AntiBac-Pred: A Web Application for Predicting Antibacterial Activity of Chemical Compounds
Q92657890AntiHIV-Pred: web-resource for in silico prediction of anti-HIV/AIDS activity
Q47226960Anticonvulsant activity and acute neurotoxic profile of Achyranthes aspera Linn
Q34597541CYCLONET--an integrated database on cell cycle regulation and carcinogenesis
Q104071505Chemical Diversity of Soft Coral Steroids and Their Pharmacological Activities
Q38232706Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review
Q27162585Collaborative development of predictive toxicology applications
Q43000088Comparative analysis of amino acid sequences from envelope proteins isolated from different hepatitis C virus variants: possible role of conservative and variable regions.
Q56973843Computer Evaluation of Drug Interactions with P-Glycoprotein
Q56973794Computer evaluation of hidden potential of phytochemicals of medicinal plants of the traditional indian ayurvedic medicine
Q100532357Computer-Aided Estimation of Biological Activity Profiles of Drug-Like Compounds Taking into Account Their Metabolism in Human Body
Q56973906Computer-Aided Prediction of Rodent Carcinogenicity by PASS and CISOC-PSCT
Q42225889Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy
Q46724646Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition
Q38702931Computer-aided prediction and cytotoxicity evaluation of dithiocarbamates of 9,10-anthracenedione as new anticancer agents
Q40118149Computer-aided prediction for medicinal chemistry via the Internet.
Q40118144Computer-aided prediction of QT-prolongation
Q55041163Computer-aided rodent carcinogenicity prediction.
Q34535339Computer-aided selection of potential antihypertensive compounds with dual mechanism of action
Q95647218Correction: QSAR without borders
Q43671204DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula.
Q92896098Data Mining Approach for Extraction of Useful Information About Biologically Active Compounds from Publications
Q96836171Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1
Q34547841Design of new cognition enhancers: from computer prediction to synthesis and biological evaluation
Q28541137Design, synthesis and pharmacological evaluation of novel vanadium-containing complexes as antidiabetic agents
Q45158369Design, synthesis, computational and biological evaluation of new anxiolytics
Q37196698Directions in QSAR modeling for regulatory uses in OECD member countries, EU and in Russia.
Q52059209Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS).
Q93092396Drug-drug interaction prediction using PASS
Q52579280Endocrine disruption profile analysis of 11,416 chemicals from chemometrical tools.
Q56973741Etoposide-Induced Apoptosis in Cancer Cells Can Be Reinforced by an Uncoupled Link between Hsp70 and Caspase-3
Q46555829Evaluation of the local anaesthetic activity of 3-aminobenzo[d]isothiazole derivatives using the rat sciatic nerve model
Q34084156Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors
Q56973870Fragment-based lead design
Q33600276Functional classification of proteins based on projection of amino acid sequences: application for prediction of protein kinase substrates
Q57469604Highly oxygenated isoprenoid lipids derived from fungi and fungal endophytes: origin and biological activities
Q45943515How good are publicly available web services that predict bioactivity profiles for drug repurposing?
Q30952705How to acquire new biological activities in old compounds by computer prediction.
Q38465804Identification of drug targets related to the induction of ventricular tachyarrhythmia through a systems chemical biology approach
Q38476075Identification of drug-induced myocardial infarction-related protein targets through the prediction of drug-target interactions and analysis of biological processes
Q90234588Improving (Q)SAR predictions by examining bias in the selection of compounds for experimental testing
Q38437547In Silico Identification of Proteins Associated with Drug-induced Liver Injury Based on the Prediction of Drug-target Interactions
Q38566364In silico assessment of adverse drug reactions and associated mechanisms
Q34174920In silico fragment-based drug design using a PASS approach.
Q39917387In silico method for identification of promising anticancer drug targets.
Q56973910Investigation of the structure and prediction of the biological activity of 1,3-bis(3-cyano-6,6-dimethyl- 2-oxo-5,6-dihydro-2H-pyran-4-yl)- 2-(4-methoxyphenyl)propane*
Q48358270MetaTox: Web Application for Predicting Structure and Toxicity of Xenobiotics' Metabolites.
Q51124082Metabolism site prediction based on xenobiotic structural formulas and PASS prediction algorithm.
Q114261873Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposing
Q47366650Molecular property diagnostic suite (MPDS): Development of disease-specific open source web portals for drug discovery.
Q55383237Multi-omics "upstream analysis" of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer.
Q33539970Multi-targeted natural products evaluation based on biological activity prediction with PASS.
Q36855838Natural peroxy anticancer agents
Q38338151Naturally occurring plant isoquinoline N-oxide alkaloids: their pharmacological and SAR activities
Q35744360Novel HIV-1 Integrase Inhibitor Development by Virtual Screening Based on QSAR Models
Q91678064Novel antimicrobial agents' discovery among the steroid derivatives
Q27921857OpenTox predictive toxicology framework: toxicological ontology and semantic media wiki-based OpenToxipedia
Q30989605PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approach
Q42693409PASS biological activity spectrum predictions in the enhanced open NCI database browser
Q56973883PASS-assisted exploration of new therapeutic potential of natural products
Q30490600PASS-based approach to predict HIV-1 reverse transcriptase resistance
Q90203545PASS-based prediction of metabolites detection in biological systems
Q56973939PASS: identification of probable targets and mechanisms of toxicity†
Q98580462Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases
Q48095195Pharmacological repositioning of Achyranthes aspera as an antidepressant using pharmacoinformatic tools PASS and PharmaExpert: a case study with wet lab validation
Q56973967Postgenomic chemistry (IUPAC Technical Report)
Q56974000Predicting Biotransformation Potential from Molecular Structure
Q101214430Prediction of Protein-ligand Interaction Based on Sequence Similarity and Ligand Structural Features
Q40150414Prediction of biological activity profiles of cyanobacterial secondary metabolites.
Q35647282Prediction of biological activity spectra via the Internet.
Q47603570Prediction of metabolites of epoxidation reaction in MetaTox
Q48703798Prediction of protein functional specificity without an alignment
Q47144673Prediction of reacting atoms for the major biotransformation reactions of organic xenobiotics
Q43881504QNA-based 'Star Track' QSAR approach.
Q38410392QSAR Modeling Using Large-Scale Databases: Case Study for HIV-1 Reverse Transcriptase Inhibitors
Q40210103QSAR Modeling and Prediction of Drug-Drug Interactions
Q56973893QSAR Modelling of Rat Acute Toxicity on the Basis of PASS Prediction
Q94477921QSAR without borders
Q36501098Quantitative prediction of antitarget interaction profiles for chemical compounds
Q33236576Rational design of macrolides by virtual screening of combinatorial libraries generated through in silico manipulation of polyketide synthases.
Q48086057Revealing Medicinal Plants That Are Useful for the Comprehensive Management of Epilepsy and Associated Comorbidities through In Silico Mining of Their Phytochemical Diversity
Q56973836Revealing pharmacodynamics of medicinal plants using in silico approach: A case study with wet lab validation
Q50947252SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds.
Q40534056Study of local anesthetic activity of some derivatives of 3-amino-benzo-[d]-isothiazole.
Q38936355Synthesis and anticancer activity of quinopimaric and maleopimaric acids’ derivatives
Q56973813Synthesis and chemoinformatics analysis of N-aryl-β-alanine derivatives
Q46712993Synthesis, antifungal activity and QSAR study of 2-arylhydroxynitroindoles
Q56973919Tools for prediction of xenobiotics interaction with human cytochrome P450
Q99593416Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease
Q35770096Virtual screening of chemical compounds active against breast cancer cell lines based on cell cycle modelling, prediction of cytotoxicity and interaction with targets
Q56973975Why relevant chemical information cannot be exchanged without disclosing structures

Search more.